Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18985338 | EVALUATION SYSTEM BASED ON ANALYTE DATA | December 2024 | January 2026 | Allow | 13 | 0 | 0 | Yes | No |
| 18970107 | ARTIFICIAL INTELLIGENCE BASED TECHNOLOGIES FOR IMPROVING PATIENT INTAKE | December 2024 | January 2026 | Allow | 13 | 0 | 0 | Yes | No |
| 18743321 | DIGITAL TWIN | June 2024 | October 2025 | Allow | 16 | 0 | 0 | Yes | No |
| 18734060 | COMPUTER-IMPLEMENTED METHODS AND EVALUATION SYSTEMS FOR EVALUATING AT LEAST ONE IMAGE DATA SET OF AN IMAGING REGION OF A PATIENT, COMPUTER PROGRAMS AND ELECTRONICALLY READABLE STORAGE MEDIUMS | June 2024 | March 2025 | Allow | 9 | 0 | 0 | Yes | No |
| 18680204 | MULTI-DIMENSIONAL PHENOTYPIC SPACE FOR GENOTYPE TO PHENOTYPE MAPPING AND INTELLIGENT DESIGN OF CANCER DRUG THERAPIES USING A DEEP LEARNING NET | May 2024 | October 2025 | Allow | 16 | 0 | 0 | Yes | No |
| 18656324 | SENSOR-BASED IOT MEDICAL INSTRUMENT USE, STERILIZATION, AND INVENTORY TRACKING SYSTEM | May 2024 | January 2026 | Allow | 20 | 1 | 0 | No | No |
| 18634608 | MEDICATION THERAPY MANAGEMENT SYSTEM AND METHODS | April 2024 | January 2026 | Allow | 21 | 1 | 0 | Yes | No |
| 18400688 | TRACKING SYSTEM FOR HOUSEHOLD ARTICLES AND SUPPLIES | December 2023 | November 2025 | Abandon | 23 | 1 | 0 | No | No |
| 18491988 | LEARNING FROM TRIAGE ANNOTATIONS | October 2023 | February 2026 | Abandon | 27 | 1 | 0 | No | No |
| 18370603 | METHODS, SYSTEMS, AND APPARATUSES FOR DOSE OPTIMIZATION | September 2023 | September 2025 | Allow | 24 | 1 | 0 | Yes | No |
| 18463413 | METHOD AND DIAGNOSTIC APPARATUS FOR DETERMINING CONSTIPATION USING MACHINE LEARNING MODEL | September 2023 | September 2025 | Allow | 24 | 1 | 0 | No | No |
| 18226708 | SYSTEMS AND METHODS FOR PROVIDING TEST RESULTS OF GENE SEQUENCING DATA ON A RECURRING BASIS | July 2023 | August 2025 | Allow | 25 | 2 | 0 | Yes | No |
| 18354830 | INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING METHOD, AND NON-TRANSITORY COMPUTER READABLE MEDIUM | July 2023 | June 2025 | Allow | 23 | 1 | 0 | Yes | No |
| 18346717 | METHOD AND SYSTEM FOR EARLY DETECTION OF COVID-19 | July 2023 | April 2025 | Allow | 22 | 0 | 0 | Yes | No |
| 18213965 | MEDICAL DEVICE MANAGEMENT METHOD AND RELATED DEVICE | June 2023 | June 2025 | Allow | 24 | 0 | 0 | Yes | No |
| 18212496 | SYSTEMS AND METHODS FOR CLUSTERING PHYSIOLOGICAL EVENTS | June 2023 | September 2025 | Allow | 27 | 1 | 0 | Yes | No |
| 18038862 | IMPROVED CLINICIAN-CENTERED CLINICAL TRIAL VERIFICATION SYSTEM AND METHOD | May 2023 | September 2025 | Abandon | 27 | 1 | 0 | No | No |
| 18037976 | SYSTEMS AND METHODS FOR ASSESSING SURGICAL ABILITY | May 2023 | June 2025 | Allow | 25 | 2 | 0 | Yes | No |
| 18143260 | MANAGEMENT AND COORDINATION OF DATA FOR DIGITAL THERAPEUTICS TRIALS | May 2023 | June 2025 | Allow | 26 | 2 | 0 | Yes | No |
| 18310816 | MEDICAL RECORD GENERATION PLATFORM | May 2023 | June 2025 | Abandon | 25 | 1 | 0 | No | No |
| 18032617 | RAPID AND DIRECT IDENTIFICATION AND DETERMINATION OF URINE BACTERIAL SUSCEPTIBILITY TO ANTIBIOTICS | April 2023 | June 2025 | Abandon | 26 | 1 | 0 | No | No |
| 18249109 | CONVEYING AGGREGATE PSYCHOLOGICAL STATES OF MULTIPLE INDIVIDUALS | April 2023 | September 2025 | Allow | 29 | 1 | 0 | Yes | No |
| 18189485 | METHODS, SYSTEMS, AND COMPUTER PROGRAM PRODUCTS FOR SELECTING CRITERIA SUBSETS FOR PERFORMING A MEDICAL NECESSITY REVIEW FOR A PATIENT CARE PLAN | March 2023 | June 2025 | Allow | 27 | 0 | 0 | Yes | No |
| 18103296 | Method And Apparatus for Evaluating Proficiency in Time Marking Section | January 2023 | August 2025 | Abandon | 30 | 1 | 0 | Yes | No |
| 18005910 | SYSTEM FOR AUTOMATICALLY EVALUATING VIRTUAL PATIENT FITTING OF MEDICAL DEVICES | January 2023 | September 2025 | Allow | 32 | 1 | 0 | Yes | No |
| 18089863 | Mental Health Anomaly Detection and Guidance | December 2022 | June 2025 | Allow | 30 | 2 | 0 | No | No |
| 18069917 | Selection Of A Wearable Article For A Medical Device | December 2022 | March 2025 | Allow | 27 | 1 | 0 | Yes | No |
| 18070240 | METHOD AND APPARATUS FOR EFFICIENTLY TRANSMITTING NUCLEIC ACID AMPLIFICATION RESULT DATA MADE BY MEASURING INSTRUMENT | November 2022 | September 2025 | Abandon | 33 | 2 | 0 | Yes | No |
| 17923958 | SYSTEM AND METHOD FOR TESTING FOR SARS-COV-2/COVID-19 BASED ON WEARABLE MEDICAL SENSORS AND NEURAL NETWORKS | November 2022 | April 2025 | Allow | 29 | 0 | 0 | Yes | No |
| 17972048 | ARTIFICIAL INTELLIGENCE TRIAGE DISPOSITION PROCESS | October 2022 | October 2025 | Allow | 36 | 2 | 0 | Yes | No |
| 18045188 | HEALTH MANAGEMENT DEVICE, HEALTH MANAGEMENT METHOD, AND HEALTH MANAGEMENT SYSTEM | October 2022 | February 2026 | Abandon | 40 | 2 | 0 | No | No |
| 17961900 | TELECOMMUNICATION APPARATUS AND METHOD | October 2022 | May 2025 | Allow | 31 | 1 | 0 | Yes | No |
| 17891063 | SYSTEMS AND METHODS FOR PROVIDING DIGITAL HEALTH SERVICES | August 2022 | September 2025 | Allow | 37 | 1 | 0 | No | No |
| 17818239 | CODE GENERATOR FOR CLINICAL RESEARCH STUDY SYSTEMS | August 2022 | March 2025 | Allow | 31 | 1 | 0 | Yes | No |
| 17815735 | SYSTEMS AND METHODS FOR RAPID VETTING OF COUNSELORS VIA GRADED SIMULATED EXCHANGES | July 2022 | August 2025 | Abandon | 36 | 2 | 0 | No | No |
| 17794680 | SYSTEM AND METHOD FOR DATA-DRIVEN INDIVIDUALIZED NUTRITION | July 2022 | June 2025 | Allow | 34 | 2 | 0 | No | No |
| 17766661 | Diagnostic Tool | April 2022 | September 2025 | Allow | 41 | 2 | 1 | No | No |
| 17763794 | EFFICIENT DIAGNOSIS OF BEHAVIORAL DISORDERS, DEVELOPMENTAL DELAYS, AND NEUROLOGICAL IMPAIRMENTS | March 2022 | September 2025 | Allow | 42 | 1 | 0 | Yes | No |
| 17638131 | SYSTEM AND METHOD FOR DEFINING A USER EXPERIENCE OF MEDICAL DATA SYSTEMS THROUGH A KNOWLEDGE GRAPH | February 2022 | December 2024 | Abandon | 34 | 1 | 0 | Yes | No |
| 17650391 | SAFE PACKAGE HANDLING | February 2022 | August 2025 | Abandon | 43 | 1 | 0 | No | No |
| 16356726 | METHODS AND SYSTEMS OF SELECTIVE MARKETING USING AGGREGATED CELEBRATORY DATES | March 2019 | September 2025 | Allow | 60 | 4 | 0 | Yes | Yes |
| 15633398 | First Party Cookie Attribution | June 2017 | September 2017 | Allow | 3 | 0 | 0 | Yes | No |
| 14176634 | ADVERTISEMENT DISTRIBUTION DEVICE AND ADVERTISEMENT DISTRIBUTION METHOD | February 2014 | May 2019 | Allow | 60 | 4 | 0 | Yes | No |
| 14133568 | GAME-BASED AUTOMATED AGENT DETECTION | December 2013 | May 2019 | Allow | 60 | 4 | 0 | Yes | No |
| 13593551 | MESSAGE SELECTION IN A MARKETING-BASED SYSTEM | August 2012 | April 2016 | Allow | 43 | 4 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner EZEWOKO, MICHAEL I.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner EZEWOKO, MICHAEL I works in Art Unit 3681 and has examined 5 patent applications in our dataset. With an allowance rate of 100.0%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 10000 months.
Examiner EZEWOKO, MICHAEL I's allowance rate of 100.0% places them in the 100% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.
On average, applications examined by EZEWOKO, MICHAEL I receive 3.20 office actions before reaching final disposition. This places the examiner in the 90% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by EZEWOKO, MICHAEL I is 10000 months. This places the examiner in the 1% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
When applicants file an RCE with this examiner, 25.0% of applications are subsequently allowed. This success rate is in the 39% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 3% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 19% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 50.0% of appeals filed. This is in the 20% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 200.0% are granted (fully or in part). This grant rate is in the 100% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 39% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 42% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.